Recombinant Human CD24 Protein-VLP, Active
Beta LifeScience
SKU/CAT #: BLK-02547P-100UG
Immobilized Human CD24 VLP at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC50 of 16.4ng/ml determined by ELISA.
Recombinant Human CD24 Protein-VLP, Active
Beta LifeScience
SKU/CAT #: BLK-02547P-100UG
Collections: Recombinant proteins, Virus-like particle (vlp) proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CD24 Protein-VLP is expressed from HEK293.It contains Ser27-Gly59. |
Accession | P25063 |
Target Symbol | CD24 |
Synonyms | CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043 |
Species | Human |
Expression System | HEK293 |
Expression Range | Ser27-Gly59 |
Mol. Weight | The target protein has a predicted MW of 5.0 kDa. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human CD24 VLP at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC50 of 16.4ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. |